Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other financing activities (2016 - 2026)

Anika Therapeutics has reported Other financing activities over the past 14 years, most recently at $1.7 million for Q1 2026.

  • Quarterly Other financing activities rose 13.02% to $1.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Mar 2026, down 56.52% year-over-year, with the annual reading at $1.6 million for FY2025, 39.71% down from the prior year.
  • Other financing activities was $1.7 million for Q1 2026 at Anika Therapeutics, up from $4000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $2.3 million in Q4 2024 and troughed at -$523000.0 in Q4 2023.
  • The 5-year median for Other financing activities is $66000.0 (2022), against an average of $398882.4.
  • Year-over-year, Other financing activities crashed 163.16% in 2023 and then surged 6278.26% in 2025.
  • A 5-year view of Other financing activities shows it stood at $828000.0 in 2022, then crashed by 163.16% to -$523000.0 in 2023, then soared by 549.14% to $2.3 million in 2024, then crashed by 99.83% to $4000.0 in 2025, then surged by 41350.0% to $1.7 million in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Other financing activities are $1.7 million (Q1 2026), $4000.0 (Q4 2025), and $13000.0 (Q3 2025).